The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Effects of Sibutramine Treatment in Obese Adolescents: A Randomized Trial
Abstract
BACKGROUND: Increased prevalence of adolescent obesity requires effective treatment options beyond behavior therapy. OBJECTIVE: To see whether sibutramine reduced weight more than placebo in obese adolescents who were receiving a behavior therapy program. DESIGN: 12-month, 3:1 randomized, double-blind trial conducted from July 2000 to February 2002. SETTING: 33 U.S. outpatient clinics. PARTICIPANTS: 498 participants 12 to 16 years of age with a body mass index (BMI) that was at least 2 units more than the U.S. weighted mean of the 95th percentile based on age and sex, to the upper limit of 44 kg/m2. INTERVENTIONS: Site-specific behavior therapy plus 10 mg of sibutramine or placebo. Blinded study medication dose was uptitrated to 15 mg or placebo at month 6 if initial BMI was not reduced by 10%. MEASUREMENTS: Body mass index, waist circumference, body weight, fasting lipid and glycemic variables, safety, and tolerability. RESULTS: Seventy-six percent of patients in the sibutramine group and 62% of patients in the placebo group completed the study. The estimated mean treatment group difference at month 12 (linear mixed-effects model) favored sibutramine for change from baseline in BMI (-2.9 kg/m2 [95% CI, -3.5 to -2.2 kg/m2]) and body weight (-8.4 kg [CI, -9.7 to -7.2 kg]) (P < 0.001 for both). The sibutramine group had greater improvements in triglyceride levels, high-density lipoprotein cholesterol levels, insulin levels, and insulin sensitivity (P < or = 0.001 for all). The rate of tachycardia was greater with sibutramine vs. placebo (12.5% vs. 6.2%; difference, 6.3 percentage points [CI, 1.0 to 11.7 percentage points]) but did not lead to increased withdrawal (2.4% vs. 1.5%; difference, 0.9 percentage point [CI, -1.7 to 3.5 percentage points]). LIMITATIONS: The 1-year study duration precluded assessment of long-term weight maintenance and putative health benefits and harms, and 24% and 38% of the sibutramine and placebo groups, respectively, did not complete follow-up. CONCLUSIONS: Sibutramine added to a behavior therapy program reduced BMI and body weight more than placebo and improved the profile of several metabolic risk factors in obese adolescents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 1×
“The degree of weight loss in our study of adolescents may delay onset of diabetes as reported in obese adults (28, 29).”
BackgroundPrevalence and Trends in Overweight Among US Children and Adolescents, 1999-2000
Ogden, C. L. (2002) · JAMA · doi:10.1001/jama.288.14.1728 · Cited by 4,060
Overweight and obesity in the United States: prevalence and trends, 1960–1994
Flegal, K., Carroll, M., Kuczmarski, R., & Johnson, C. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800541 · Cited by 3,045
Freedman, D. S., Dietz, W. H., Srinivasan, S. R., & Berenson, G. S. (1999) · Pediatrics · doi:10.1542/peds.103.6.1175 · Cited by 2,456 · cited 2×
“Any adverse event 327 (89) 111 (85) Infection 167 (45) 53 (41) Headache 113 (31) 39 (30) Pharyngitis 49 (13) 23 (18) Tachycardia† 46 (13) 8 (6) Accidental injury 41 (11) 8 (6) Dry mouth 41 (11) 8 (6) Pain 42 (11) 12 (9) Hypertension 39 (11) 11 (8) Rhinitis 41 (11) 17 (13) Abdominal pain 37 (10) 12 (9) Dysmenorrhea‡ 21…”
BackgroundMust, A., Jacques, P. F., Dallal, G. E., Bajema, C. J., & Dietz, W. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211053271904 · Cited by 2,233
XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study
Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.155 · Cited by 1,915 · cited 1×
“Any adverse event 327 (89) 111 (85) Infection 167 (45) 53 (41) Headache 113 (31) 39 (30) Pharyngitis 49 (13) 23 (18) Tachycardia† 46 (13) 8 (6) Accidental injury 41 (11) 8 (6) Dry mouth 41 (11) 8 (6) Pain 42 (11) 12 (9) Hypertension 39 (11) 11 (8) Rhinitis 41 (11) 17 (13) Abdominal pain 37 (10) 12 (9) Dysmenorrhea‡ 21…”
Emerging epidemic of type 2 diabetes in youth
Rosenbloom, A. L., Joe, J. R., Young, R. S., & Winter, W. E. (1999) · Diabetes Care · doi:10.2337/diacare.22.2.345 · Cited by 1,019 · cited 1×
“Any adverse event 327 (89) 111 (85) Infection 167 (45) 53 (41) Headache 113 (31) 39 (30) Pharyngitis 49 (13) 23 (18) Tachycardia† 46 (13) 8 (6) Accidental injury 41 (11) 8 (6) Dry mouth 41 (11) 8 (6) Pain 42 (11) 12 (9) Hypertension 39 (11) 11 (8) Rhinitis 41 (11) 17 (13) Abdominal pain 37 (10) 12 (9) Dysmenorrhea‡ 21…”
Effect of sibutramine on weight maintenance after weight loss: a randomised trial
James, W. P. T., Astrup, A., Finer, N., Hilsted, J., Kopelman, P., Rössner, S., Saris, W. H. M., & Gaal, L. F. V. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03491-7 · Cited by 817
Cited by
Barlow, S. E., & and the Expert Committee (2007) · Pediatrics · doi:10.1542/peds.2007-2329c · Cited by 4,497
Interventions for treating obesity in children
Oude Luttikhuis, H., Baur, L., Jansen, H., Shrewsbury, V. A., O'Malley, C., Stolk, R. P., & Summerbell, C. D. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001872.pub2 · Cited by 1,531
RetractedHan, J. C., Lawlor, D. A., & Kimm, S. Y. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60171-7 · Cited by 1,309
Styne, D. M., Arslanian, S. A., Connor, E. L., Farooqi, I. S., Murad, M. H., Silverstein, J. H., & Yanovski, J. A. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2573 · Cited by 1,282
Recommendations for Treatment of Child and Adolescent Overweight and Obesity
Spear, B. A., Barlow, S. E., Ervin, C., Ludwig, D. S., Saelens, B. E., Schetzina, K. E., & Taveras, E. M. (2007) · Pediatrics · doi:10.1542/peds.2007-2329f · Cited by 856
Metadata
- Authors
- Berkowitz, R. I., Fujioka, K., Daniels, S. R., Hoppin, A. G., Owen, S., Perry, A. C., Sothern, M. S., Renz, C. L., Pirner, M. A., Walch, J. K., Jasinsky, O., Hewkin, A. C., Blakesley, V. A., & for the Sibutramine Adolescent Study Group*
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2006-07-18
- Volume
- 145
- Issue
- 2
- Pages
- 81-90
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2125226484
- Cited by
- 220
- References
- 9
- FWCI
- 22.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of Sibutramine Treatment in Obese Adolescents: A Randomized Trial. https://app.cochat.ai/papers/10.7326/0003-4819-145-2-200607180-00005
- The paper
- Berkowitz, R. I., Fujioka, K., Daniels, S. R., Hoppin, A. G., Owen, S., Perry, A. C., Sothern, M. S., Renz, C. L., Pirner, M. A., Walch, J. K., Jasinsky, O., Hewkin, A. C., Blakesley, V. A., & for the Sibutramine Adolescent Study Group*. (2006). Effects of Sibutramine Treatment in Obese Adolescents: A Randomized Trial. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-145-2-200607180-00005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.